CV Risks and Benefits of Menopausal Hormone Therapy and SERMS

Learn the evidence and guidelines related to menopausal hormone therapy or selective estrogen receptor modulators) in treating menopausal symptoms, including its role in CVD risk reduction.

Women and Heart Disease
Member Cost: $0Non-member Cost: $0
Credit Hours: 0.75 CE contact hours

Course Overview

Register

CVD Risk and Hormone Therapy

Learn the evidence and guidelines related to menopausal hormone therapy or selective estrogen receptor modulators in treating menopausal symptoms, including their role in CVD risk reduction.

Learning Objectives

Upon completion of this continuing education course, participants will be able to:

  • Describe an evidence-based approach to shared decision making for the clinician and peri-menopausal patient considering menopausal hormone therapy or selective estrogen receptor modulators

Faculty

  • Cynthia Stuenkel, MD, NCMP